BRAND_ANALYSIS #ASTRAZENECA HEALTH & PHARMA #23 OF 26 IN HEALTH & PHARMA ALIGNED

AstraZeneca

· Public · Updated 09 Sep 2026 07:29 UTC
#1009 of 1208 overall by tension · #23 of 26 in Health & Pharma
8 Aligned
The Aligned Power
Analysis

Pharma's bargain: 73 business points for 65 cultural ones, a 0.848 wiki_ratio proof that drug companies never become famous for the right reasons. Flat stock performance masks the reputational debt.

IN THE NEWS (100 articles this week)
Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer - astrazeneca.com
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes - CNBC
AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies - STAT
Cultural Score
65 / 100
Business Score
73 / 100
TENSION▁▁▁▂▁▂▂▁▁▂▂▂▂▁
CULTURAL▅▅▅▅▅▅▅▅▅▅▅▅▄▅
BUSINESS▅▅▆▆▆▆▆▅▅▆▆▆▆▆
Loading...
Wikipedia Momentum 22/40
News Presence 43/35
Search InterestRedistributed to other dimensions
Stock Momentum 16/30
Market Position 22/25
Revenue Growth 19/25
Earnings Health 16/20
Avg Daily (7d)417
Avg Daily (90d)492
7d/90d Ratio0.85x
Price$160.04
30d Change-0.8%
Market Cap$248.2B
Profit Margin17.0%
AstraZeneca's tension is 8. Commerce outpacing culture. sociologyofcapitalism.com/brand/astrazeneca
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/astrazeneca.html" width="320" height="200" frameborder="0"></iframe>